Bempedoic Acid Pregnancy Surveillance Program
NCT05103254 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2024-05-17
Summary
Bempedoic acid pregnancy surveillance program
Conditions
- Pregnancy
- Hyperlipidemias
Interventions
- DRUG
-
Bempedoic Acid 180 MG
- DRUG
-
Bempedoic Acid / Ezetimibe
Bempedoic Acid 180 MG / Ezetimibe 10 MG
Sponsors & Collaborators
-
Esperion Therapeutics, Inc.
lead INDUSTRY
Principal Investigators
-
Christine Broestl, MS · Esperion Therapuetics
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-09-01
- Primary Completion
- 2032-05-31
- Completion
- 2032-05-31
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Lipid Metabolism in Gestational Diabetes
NCT00534105 ·Status: COMPLETED
-
Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy
NCT00721591 ·Status: COMPLETED
-
The Heart Outcomes in Pregnancy Expectations for Mom and Baby Study
NCT06517628 ·Status: RECRUITING
-
Low Molecular Weight Heparin in Pregnancies With Unexplained Stillbirths
NCT03601338 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Prospective Study in Pregnant Women With Hypercoagulopathy
NCT00215969 ·Status: UNKNOWN
-
Prediction of Preeclampsia & Other Obstetric Complications by Serum Homocysteine & Doppler
NCT02541110 ·Status: UNKNOWN
-
A Randomized, Placebo-controlled Trial of DAPAgliflozin (DAPA) for Cardiovascular Risk Reduction in the Postpartum Period of Hypertensive Pregnancies (HP)
NCT06785116 ·Status: RECRUITING ·Phase: PHASE4
-
Lipid Profile as Predictor of Adverse Maternal and Neonatal Outcomes: A Pilot Study
NCT05535660 ·Status: COMPLETED
-
Ursodeoxycholic Acid And Cholestasis Of Pregnancy
NCT01226823 ·Status: WITHDRAWN ·Phase: PHASE3
-
Impedance Cardiography to Decrease the Risk of Preeclampsia
NCT03245970 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Safety Study of Fenofibrate During Pregnancy
NCT05883865 ·Status: RECRUITING
-
Use of Impedance Cardiography to Decrease the Risk of Pre-eclampsia in Obese Patients
NCT03105661 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
NT-proBNP Levels in the Prediction of Intrapartum and Postpartum Events in Adult Congenital Heart Disease Patients
NCT04231591 ·Status: COMPLETED
-
Antenatal COVID 19 Vaccination and Pregnancy Outcomes
NCT05401825 ·Status: UNKNOWN
-
Transplacental Transfer of Drugs Used in Pregnant Women
NCT02622802 ·Status: COMPLETED ·Phase: NA
-
Insulin Pre-treatment for Steroid-associated Hyperglycemia in Pregnant Diabetic Patients
NCT01875107 ·Status: WITHDRAWN ·Phase: PHASE4
-
Development of an International Remote Digital Care System for Accessible, Inclusive and Sustainable Pregnancy Care
NCT07191236 ·Status: ENROLLING_BY_INVITATION
-
Pregnancy and Risk of Venous Thromboembolism
NCT03659708 ·Status: RECRUITING ·Phase: NA
-
Second Trimester Maternal Serum Homocysteine Levels and Uterine Artery Doppler for Prediction of Preeclampsia and Placentation Disorders
NCT02854501 ·Status: COMPLETED
-
Study of Association Between Maternal Uric Acid , Maternal and Fetal Outcome in Pregnant Women With Hypertension
NCT01523327 ·Status: UNKNOWN
-
Observational Study in UTERO - Placental 3D Doppler Examination: Interest for Pre-eclampsia Screening During Pregnancy
NCT00930397 ·Status: COMPLETED
-
Metformin for Preeclampsia Prevention in Pregnant Women With Type 1 Diabetes Mellitus
NCT03570632 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
The Belgian Diabetes in Pregnancy Study: BEDIP-N Study
NCT02036619 ·Status: COMPLETED
-
Clinical Follow-up of Pregnant Subjects Undergoing NIPT
NCT04595201 ·Status: RECRUITING
-
A Comparison of Compliance Between Clonidine Patch and Methyldopa for the Treatment of Chronic Hypertension in Pregnancy
NCT00329511 ·Status: WITHDRAWN ·Phase: NA